CICN.SW Cicor Technologies (SIX) pre-market CHF125.50 Jan 27 2026: AI tailwind
CICN.SW stock trades pre-market at CHF125.50 on 27 Jan 2026 after opening at CHF124.50 on the SIX Swiss Exchange. Investors will watch Cicor Technologies Ltd. for AI-driven demand in advanced microelectronics and substrates that serve medical, aerospace and communication customers. Key metrics include EPS CHF5.30, PE 23.68, market cap CHF547,348,170.00, and an upcoming earnings date on 2026-03-11. We use Meyka AI-powered market analysis platform data to connect fundamentals, technicals and AI sector trends to short and medium-term outlooks for CICN.SW stock.
CICN.SW stock: Pre-market snapshot and core metrics
CICN.SW stock is at CHF125.50 with a pre-market open of CHF124.50 and intraday range CHF122.50–CHF126.00. Volume is 12,018 shares versus an average of 19,661.00. Market capitalization is CHF547,348,170.00 and shares outstanding are 4,361,340.00.
Earnings per share are CHF5.30 with a reported PE of 23.68 and EPS-based guidance reflected in an earnings announcement on 2026-03-11. These exact figures set the baseline for short-term moves in the pre-market trading session on the SIX in Switzerland.
CICN.SW stock: Recent performance and sector context
CICN.SW stock is down 35.48% over three months but up 94.27% year-on-year, showing volatility tied to sector cycles. The 50-day average is CHF145.42 and the 200-day average is CHF159.34, both above the current price and indicating shorter-term weakness.
The company sits in the Technology sector where the average PE is 28.60. Cicor’s valuation metrics compare against peers in hardware and semiconductor supply chains, and AI demand for substrates can create revenue tailwinds if industrial and medical orders climb.
CICN.SW stock: Financials and valuation metrics
Key valuation and balance sheet metrics show revenue per share CHF59.77, net income per share CHF3.13, book value per share CHF33.21, and cash per share CHF10.87. Debt-to-equity stands at 0.82, and net debt to EBITDA is 2.88, reflecting moderate leverage.
Profitability ratios include ROE 9.84%, operating margin 7.33%, and free cash flow yield 5.19%. Note the model TTM PE of 40.15 differs from the quoted PE of 23.68, a gap analysts reconcile by differing trailing windows and one-off items. Use both figures when valuing CICN.SW stock.
CICN.SW stock: Technical and trading signals
Technical indicators show RSI 37.11, MACD histogram 1.78, and ADX 36.97 indicating a strong trend but with short-term weakness. Bollinger band middle is CHF133.75 and ATR is CHF7.97, suggesting wider intraday swings.
On-chain volume metrics show on-balance volume negative and relative volume 0.61, so trading interest is below average. Traders may watch RSI near 35–40 for a potential base and a cross above the 50-day average CHF145.42 for trend confirmation.
Meyka grade and CICN.SW stock price forecasts
Meyka AI rates CICN.SW with a score out of 100: 76.62 (Grade B+) with a suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are informational and not financial advice.
Meyka AI’s forecast model projects a 1-month target of CHF143.63 (implied upside 14.45% vs CHF125.50) and a 1-year target of CHF229.29 (implied upside 82.75%). Forecasts are model-based projections and not guarantees. For risk management, consider a conservative near-term price target of CHF140.00, base CHF180.00, and bull CHF260.00, tied to order momentum in AI hardware.
CICN.SW stock: Catalysts and principal risks
Near-term catalysts include the 2026-03-11 earnings report, new order announcements from aerospace and medical clients, and any acceleration in AI hardware spending that requires advanced substrates and microelectronics. Positive surprises could re-rate CICN.SW stock toward the 50-day average.
Key risks are long inventory cycles (days inventory on hand 502.99), stretched cash conversion cycles, thin interest coverage 1.05, and sensitive margins if raw-material costs rise. Geopolitical supply-chain shocks or weaker industrial end-markets would pressure the stock.
Final Thoughts
CICN.SW stock trades at CHF125.50 in pre-market on 27 Jan 2026 with mixed signals: strong year-on-year gains but short-term weakness and averages above the current price. Financially, Cicor shows healthy free cash flow per share CHF6.30 and book value CHF33.21, while leverage and long inventory cycles are watch points. Technically, RSI 37.11 and ADX 36.97 imply a strong but down-trending move that needs demand catalysts to reverse.
Meyka AI’s forecast model projects CHF143.63 in one month (implied upside 14.45%) and CHF229.29 in one year (implied upside 82.75%) versus the current price of CHF125.50. These projections assume continued AI-related demand for substrates and microelectronics and improved order flow. Forecasts are model-based projections and not guarantees. Investors should weigh the B+ (BUY) grade from Meyka AI against operational risks and upcoming earnings on 2026-03-11, and use position sizing and stop levels aligned with the stock’s volatility.
FAQs
What is the current price and market cap for CICN.SW stock?
CICN.SW stock is trading pre-market at CHF125.50 with a market cap of CHF547,348,170.00 on the SIX Swiss Exchange as of 27 Jan 2026. Volume in the pre-market session was 12,018 shares.
What are Meyka AI’s forecasts and the implied upside for CICN.SW stock?
Meyka AI’s forecast model projects CHF143.63 in one month (implied upside 14.45%) and CHF229.29 in one year (implied upside 82.75%) versus the current price CHF125.50. Forecasts are model-based projections and not guarantees.
What are the main risks investors should track for CICN.SW stock?
Key risks for CICN.SW stock include long inventory days (502.99), low interest coverage (1.05), leverage (debt-to-equity 0.82), and end-market cyclicality. Watch earnings on 2026-03-11 for order and margin signals.
How does CICN.SW stock fit the AI stocks strategy?
Cicor supplies substrates and microelectronics used in AI hardware and medical devices. That exposure means CICN.SW stock can benefit from rising AI hardware orders, though performance depends on execution, margins and supply-chain stability.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
